PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

AMGEN INC.

DC · US

Healthcare/Biotechnology

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

Connections

15

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Lobbied forInflation Reduction Act - Energy Provisions (H.R.5376)LDA filing: lobbied on Inflation Reduction Act - Energy, period 1st Quarter (Jan 1 - Mar 31), reported amount $3,330,000Source
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000Source
Employed byEMPIRE CONSULTING GROUPHired EMPIRE CONSULTING GROUP to lobby on PBM Reform ActSource
Employed byTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby on NIH March-In RightsSource
Lobbied forBIOSECURE Act (H.R.8333/S.3558)LDA filing: lobbied on BIOSECURE Act, period 2nd Quarter (Apr 1 - June 30), reported amount $2,740,000Source
Lobbied forMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source
Employed byTIBER CREEK GROUPHired TIBER CREEK GROUP to lobby on PharmaceuticalsSource
Employed byJEFFREY J. KIMBELL & ASSOCIATES, INC.Hired JEFFREY J. KIMBELL & ASSOCIATES, INC. to lobby on PharmaceuticalsSource
Employed byHILLNORTH LLCHired HILLNORTH LLC to lobby on PharmaceuticalsSource
Employed byTARPLIN, DOWNS & YOUNG, LLCHired TARPLIN, DOWNS & YOUNG, LLC to lobby on PharmaceuticalsSource
Employed byCapitol Counsel, LLCHired CAPITOL COUNSEL LLC to lobby on PharmaceuticalsSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2025-0240: Medicare Program: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney ISource
Lobbied forInflation Reduction Act - Drug Pricing Provisions (H.R.5376)LDA filing: lobbied on IRA Drug Pricing Provisions, period 1st Quarter (Jan 1 - Mar 31), reported amount $3,330,000Source
Employed byTIBER CREEK HEALTH STRATEGIES, INC.Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PharmaceuticalsSource
Parent ofHORIZON THERAPEUTICSHorizon Therapeutics was acquired by Amgen in 2023Source